Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest GREAT POINT PARTNERS LLC Stock Portfolio

$522Million– No. of Holdings #33

GREAT POINT PARTNERS LLC Performance:
2024 Q2: -5.05%YTD: 10.2%2023: 5.9%

Performance for 2024 Q2 is -5.05%, and YTD is 10.2%, and 2023 is 5.9%.

About GREAT POINT PARTNERS LLC and 13F Hedge Fund Stock Holdings

GREAT POINT PARTNERS LLC is a hedge fund based in GREENWICH, CT. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.9 Billions. In it's latest 13F Holdings report, GREAT POINT PARTNERS LLC reported an equity portfolio of $522 Millions as of 30 Jun, 2024.

The top stock holdings of GREAT POINT PARTNERS LLC are URGN, , . The fund has invested 9.3% of it's portfolio in UROGEN PHARMA LTD and 7% of portfolio in NEUROGENE INC.

The fund managers got completely rid off ALPINE IMMUNE SCIENCES INC (ALPN), APOGEE THERAPEUTICS INC and AEROVATE THERAPEUTICS INC (AVTE) stocks. They significantly reduced their stock positions in ANAPTYSBIO INC (ANAB), INSMED INC (INSM) and VIRIDIAN THERAPEUTICS INC (VRDN). GREAT POINT PARTNERS LLC opened new stock positions in KALVISTA PHARMACEUTICALS INC (KALV), IONIS PHARMACEUTICALS INC (IONS) and CONTEXT THERAPEUTICS INC (CNTX). The fund showed a lot of confidence in some stocks as they added substantially to KYVERNA THERAPEUTICS INC, AUTOLUS THERAPEUTICS PLC (AUTL) and CYTOKINETICS INC (CYTK).
GREAT POINT PARTNERS LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024

GREAT POINT PARTNERS LLC Annual Return Estimates Vs S&P 500

Our best estimate is that GREAT POINT PARTNERS LLC made a return of -5.05% in the last quarter. In trailing 12 months, it's portfolio return was 28.26%.

New Buys

Ticker$ Bought
kalvista pharmaceuticals inc15,768,300
ionis pharmaceuticals inc15,727,800
context therapeutics inc14,875,800
voyager therapeutics inc12,668,100
olema pharmaceuticals inc8,622,240
tscan therapeutics inc5,503,860
lexicon pharmaceuticals inc50,400

New stocks bought by GREAT POINT PARTNERS LLC

Additions

Ticker% Inc.
kyverna therapeutics inc232
autolus therapeutics plc195
cytokinetics inc134
merus n v134
dynavax technologies corp87.68
zura bio ltd68.33
arcellx inc64.00
optinose inc56.23

Additions to existing portfolio by GREAT POINT PARTNERS LLC

Reductions

Ticker% Reduced
anaptysbio inc-97.44
insmed inc-67.77
viridian therapeutics inc-62.55
esperion therapeutics inc ne-27.61
vistagen therapeutics inc-17.72
terns pharmaceuticals inc-12.26
jasper therapeutics inc-1.36
abivax sa-0.65

GREAT POINT PARTNERS LLC reduced stake in above stock

Sold off

Ticker$ Sold
mind medicine mindmed inc-18,800,000
ocular therapeutix inc-15,731,400
alpine immune sciences inc-44,733,700
aerovate therapeutics inc-26,249,000
xenon pharmaceuticals inc-19,637,200
apogee therapeutics inc-26,580,000
intra-cellular therapies inc-10,380,000
immunocore hldgs plc-7,475,000

GREAT POINT PARTNERS LLC got rid off the above stocks

Sector Distribution

GREAT POINT PARTNERS LLC has about 77.2% of it's holdings in Healthcare sector.

Sector%
Healthcare77.2
Others22.8

Market Cap. Distribution

GREAT POINT PARTNERS LLC has about 3.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP39.1
UNALLOCATED25.1
MID-CAP21.9
MICRO-CAP10.7
LARGE-CAP3.2

Stocks belong to which Index?

About 56.3% of the stocks held by GREAT POINT PARTNERS LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200056.3
Others43.7
Top 5 Winners (%)%
INSM
insmed inc
46.1 %
MRUS
merus n v
28.6 %
IONS
ionis pharmaceuticals inc
16.4 %
URGN
urogen pharma ltd
12.8 %
CNTX
context therapeutics inc
8.1 %
Top 5 Winners ($)$
INSM
insmed inc
9.7 M
MRUS
merus n v
6.9 M
URGN
urogen pharma ltd
5.5 M
IONS
ionis pharmaceuticals inc
2.2 M
ANAB
anaptysbio inc
1.3 M
Top 5 Losers (%)%
PBYI
puma biotechnology inc
-37.6 %
OTLK
outlook therapeutics inc
-35.3 %
VRDN
viridian therapeutics inc
-25.3 %
TCRX
tscan therapeutics inc
-24.4 %
PLRX
pliant therapeutics inc
-23.9 %
Top 5 Losers ($)$
PLRX
pliant therapeutics inc
-8.9 M
EOLS
evolus inc
-7.7 M
OTLK
outlook therapeutics inc
-6.8 M
VRDN
viridian therapeutics inc
-5.9 M
CYTK
cytokinetics inc
-4.9 M

GREAT POINT PARTNERS LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of GREAT POINT PARTNERS LLC

GREAT POINT PARTNERS LLC has 33 stocks in it's portfolio. About 58% of the portfolio is in top 10 stocks. PLRX proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for GREAT POINT PARTNERS LLC last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions